相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。In vitro activity of the novel antifungal olorofim against dermatophytes and opportunistic moulds including Penicillium and Talaromyces species
Ashutosh Singh et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)
Madurella mycetomatis, the main causative agent of eumycetoma, is highly susceptible to olorofim
Wilson Lim et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
Innovative therapies for invasive fungal infections in preclinical and clinical development
Yidong Yu et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2020)
Efficacy of Olorofim (F901318) against Aspergillus fumigatus, A. nidulans, and A. tanneri in Murine Models of Profound Neutropenia and Chronic Granulomatous Disease
S. Seyedmousavi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
In vitro activity of olorofim (F901318) against clinical isolates of cryptic species of Aspergillus by EUCAST and CLSI methodologies
Olga Rivero-Menendez et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
In Vitro Activity of APX001A (Manogepix) and Comparator Agents against 1,706 Fungal Isolates Collected during an International Surveillance Program in 2017
M. A. Pfaller et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
9th Trends in Medical Mycology held on 11-14 October 2019, Nice, France, Organized under the Auspices of EORTC-IDG and ECMM Abstracts
[Anonymous]
JOURNAL OF FUNGI (2019)
Pharmacodynamics of the Novel Antifungal Agent F901318 for Acute Sinopulmonary Aspergillosis Caused by Aspergillus flavus
Clara E. Negri et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
The Orotomide Olorofim Is Efficacious in an Experimental Model of Central Nervous System Coccidioidomycosis
Nathan P. Wiederhold et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Susceptibility profile of echinocandins, azoles and amphotericin B against yeast phase of Talaromyces marneffei isolated from HIV-infected patients in Guangdong, China
H. -L. Lei et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2018)
In vitro activity of the novel antifungal compound F901318 against Australian Scedosporium and Lomentospora fungi
Chayanika Biswas et al.
MEDICAL MYCOLOGY (2018)
In Vitro Activity of Posaconazole against Talaromyces marneffei by Broth Microdilution and Etest Methods and Comparison to Itraconazole, Voriconazole, and Anidulafungin
Susanna K. P. Lau et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
In vitro activity of the novel antifungal compound F901318 against difficult-to-treat Aspergillus isolates
J. B. Buil et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Dihydroorotate dehydrogenase inhibitor F901318 has potent in vitro activity against Scedosporium species and Lomentospora prolificans
Nathan P. Wiederhold et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Pharmacodynamics of the Orotomides against Aspergillus fumigatus: New Opportunities for Treatment of Multidrug-Resistant Fungal Disease
William W. Hope et al.
MBIO (2017)
F901318 represents a novel class of antifungal drug that inhibits dihydroorotate dehydrogenase
Jason D. Oliver et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Antifungal Activities of SCY-078 (MK-3118) and Standard Antifungal Agents against Clinical Non-Aspergillus Mold Isolates
Frederic Lamoth et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Neglected fungal zoonoses: hidden threats to man and animals
S. Seyedmousavi et al.
CLINICAL MICROBIOLOGY AND INFECTION (2015)
Penicillium marneffei Infection: An Emerging Disease in Mainland China
Yongxuan Hu et al.
MYCOPATHOLOGIA (2013)
Investigation of dogs as a reservoir of Penicillium marneffei in northern Thailand
Benjaporn Chaiwun et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2011)
Penicillium marneffei infection and recent advances in the epidemiology and molecular biology aspects
N Vanittanakom et al.
CLINICAL MICROBIOLOGY REVIEWS (2006)
Efficacy of albaconazole (UR-9825) in treatment of disseminated Scedosporium prolificans infection in rabbits
J Capilla et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Disseminated Penicillium marneffei infection among HIV-infected patients in Manipur State, India
KH Ranjana et al.
JOURNAL OF INFECTION (2002)
In vitro activities of four novel triazoles against Scedosporium spp.
AJ Carrillo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)